These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2408887)

  • 1. Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F.
    Hancock RE; Mutharia LM; Mouat EC
    Eur J Clin Microbiol; 1985 Apr; 4(2):224-7. PubMed ID: 2408887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two surface-localized antigenic sites on porin protein F of Pseudomonas aeruginosa.
    Mutharia LM; Hancock RE
    Can J Microbiol; 1985 Apr; 31(4):381-6. PubMed ID: 2408719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against bacterial outer membrane antigens.
    Hancock RE; Mutharia LM
    Adv Exp Med Biol; 1985; 185():215-22. PubMed ID: 2416201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice.
    O'Oka H; Chonan E; Mizutani K; Fukuda T; Kuroiwa Y; Ono Y; Shigeta S
    Microbiol Immunol; 1992; 36(12):1305-16. PubMed ID: 1287405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies.
    Mutharia LM; Hancock RE
    Infect Immun; 1983 Dec; 42(3):1027-33. PubMed ID: 6315589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.
    Horn MP; Zuercher AW; Imboden MA; Rudolf MP; Lazar H; Wu H; Hoiby N; Fas SC; Lang AB
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2338-44. PubMed ID: 20308370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of antibody to the ferripyochelin-binding protein of Pseudomonas aeruginosa.
    Sokol PA; Woods DE
    Infect Immun; 1986 Mar; 51(3):896-900. PubMed ID: 3081447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines and immunotherapy against Pseudomonas aeruginosa.
    Döring G; Pier GB
    Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of immunosuppressed mice against infection with pseudomonas aeruginosa by monoclonal antibodies to outer membrane protein OprI.
    Rahner R; Eckhardt A; Duchêne M; Domdey H; von Specht BU
    Infection; 1990; 18(4):242-5. PubMed ID: 2120132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of protective mAbs against Pseudomonas aeruginosa outer membrane protein I by C1q binding assay.
    Eckhardt A; Heiss MM; Ehret W; Permanetter W; Duchêne M; Domdey H; von Specht BU
    Zentralbl Bakteriol; 1991 Apr; 275(1):100-11. PubMed ID: 1930557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonial dissociation and susceptibility to phagocytosis of Pseudomonas aeruginosa grown in a chamber implant model in mice.
    Kelly NM; Battershill JL; Kuo S; Arbuthnott JP; Hancock RE
    Infect Immun; 1987 Nov; 55(11):2841-3. PubMed ID: 3117694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].
    Moss RB
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():42-6; discussion 47. PubMed ID: 8499750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response in cystic fibrosis to outer membrane proteins of Pseudomonas aeruginosa.
    Kubesch P; von Specht BU; Tümmler B
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):395-410. PubMed ID: 3146171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis.
    Hancock RE; Mouat EC; Speert DP
    J Infect Dis; 1984 Feb; 149(2):220-6. PubMed ID: 6421943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa.
    DiGiandomenico A; Keller AE; Gao C; Rainey GJ; Warrener P; Camara MM; Bonnell J; Fleming R; Bezabeh B; Dimasi N; Sellman BR; Hilliard J; Guenther CM; Datta V; Zhao W; Gao C; Yu XQ; Suzich JA; Stover CK
    Sci Transl Med; 2014 Nov; 6(262):262ra155. PubMed ID: 25391481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.
    Thomsen K; Christophersen L; Jensen PØ; Bjarnsholt T; Moser C; Høiby N
    Hum Vaccin Immunother; 2016 Jul; 12(7):1690-9. PubMed ID: 26901841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
    Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.